Added benefit of lixisenatide is not proven ( Institute for Quality and Efficiency in Health Care ) No added benefit of the antidiabetic lixisenatide in comparison with current standard therapy can be derived from the dossier because the drug manufacturer did not present any suitable data.
Aug. 2, 2013 - EurekAlert!